Nissan to Cut Global Lineup, Infuse Models with AI Driving Tech
By Reuters | 13 Apr, 2026
Nissan plans to reduce its global lineup from 56 models to 45 while deploying AI driving technology across most over the long term.
Nissan Motor said on Tuesday it plans to streamline its global lineup to 45 models from 56 by exiting low-performing ones and seek to deploy its artificial intelligence driving technology across 90% of its lineup over the long term.
The company said in a statement its ambition was to reach annual sales of 1 million vehicles in both the United States and China by the 2030 financial year and grow its annual sales volume in Japan to 550,000 cars by that time.
Nissan said it will give an update on the progress of its restructuring plan when it reports full-year financial results next month and announce further elements of its strategic direction later in the year.
Japan's fourth-biggest automaker said it will establish exports as a strategic pillar in China, shipping its N7 electric sedan to Latin America and ASEAN, and its Frontier Pro pickup truck to the Middle East in addition to those markets.
The company will aim to produce more vehicles in the U.S. by raising its local production rate to 80% over time from around 60% currently, and revitalise its Infiniti luxury brand by introducing new models.
In Japan, the automaker will introduce a compact car series from the 2028 financial year, it said.
(Reporting by Daniel Leussink; Editing by Chang-Ran Kim and Muralikumar Anantharaman)
Recent Articles
- Anterior to the Heart
- Meta to Capture Employee Mouse Movements, Keystrokes for AI Training
- Judge Blocks Trump Policies Stymying Solar, Wind Projects
- Thousands of Companies File Refund Claims As Tariff Refund System Opens
- Volkswagen to Cut Another 1 Million from Annual Capacity
- China's Changan Aims to Join World's top-10 Carmakers by 2030
- Great Wall Motor to Launch 10 New Cars for European Comeback
- Taiwan Exports Orders Surge to Fastest Pace in Over 16 Years
- Many Americans Question Trump’s Temperament
- COVID Shots, Newer Vaccines in Limbo After Court Dinged Kennedy’s Advisory Panel
